Progentec
James W. is an experienced legal professional with a robust background in the biotechnology and pharmaceutical industries. Currently serving as Co-Founder, Chairman, and Chief Legal/Administrative Officer at Qnapsyn Biosciences, Inc. since August 2020, James is instrumental in the development of innovative pharmaceutical solutions for various disorders. Concurrently, James holds the position of General Counsel at Progentec Diagnostics, Inc., focusing on advanced diagnostic interventions. As the Principal at Wilcox Group since July 1998, James offers extensive legal consulting services, particularly in corporate governance and intellectual property. Prior experience includes key roles at Immunicon Corporation, Enriched Air Inc., Fuisz Technologies, Ltd., and Abbott Laboratories, where James established legal departments, managed corporate transactions, and handled intellectual property matters.
This person is not in any teams
This person is not in any offices
Progentec
2 followers
Progentec is a next-gen diagnostics company developing blood-based and digital biomarkers to transform the care of people living with autoimmune diseases